Yang, Wanlin
Jin, Min
Gu, Yuting
Zhao, Xiaonan
Zhu, Lingqiao
He, Shan
Wang, Hui
Ding, Xinyuan
Wang, Bei
Jiang, Tingwang
Xiao, Yichuan
Zhou, Guoqiang
Huang, Jiefang
Zhang, Yanyun https://orcid.org/0000-0002-8990-8220
Funding for this research was provided by:
National Natural Science Foundation of China (82271589)
National Natural Science Foundation of China (82300584)
National Natural Science Foundation of China (82000567)
National Natural Science Foundation of China (82000553)
National Natural Science Foundation of China (82001739)
National Natural Science Foundation of China (82070191)
National Natural Science Foundation of China (82071727)
National Key R&D Program of China (2018YFA010720)
Article History
Received: 12 June 2024
Accepted: 5 October 2024
First Online: 15 October 2024
Declarations
:
: The animal protocol (SINH-2020-ZYY-2), titled “Inflammatory and immune-related diseases” approved in September 2021 was performed according to the guidelines of the Institutional Animal Care and Use Committee of the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and complied with the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health. The reporting of animal experiments adheres to the ARRIVE guidelines.
: Not applicable.
: The authors declare that they have no competing interests.